AI & ChatGPT searches , social queriess for HCV GENOTYPES
Search references for HCV GENOTYPES. Phrases containing HCV GENOTYPES
See searches and references containing HCV GENOTYPES!
Search references for HCV GENOTYPES. Phrases containing HCV GENOTYPES
See searches and references containing HCV GENOTYPES!HCV GENOTYPES
The genotype can affect treatment of HCV infections. Recent studies show that HCV genotypes consist of 8 genotypes and 67 subtypes. All the genotypes and
HCV_genotypes
Species of virus
(2011). "NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b". Virol. J. 8 317. doi:10.1186/1743-422X-8-317
Hepatitis_C_virus
Human viral infection
family Hepacivirus. There are seven major genotypes of HCV, which are known as genotypes one to seven. The genotypes are divided into several subtypes with
Hepatitis_C
Pharmaceutical drug
ages 6 to 11 years with HCV genotypes 1, 2, 3 or 4, 93% with genotype 1, 91% with genotype 3 and 100% with genotypes 2 and genotype 4 had no virus detected
Sofosbuvir/velpatasvir
Possible vaccine and research into it
first approved vaccine will likely only target genotypes 1a and 1b, which account for over 60% of chronic HCV infections worldwide. Likely, vaccines following
Hepatitis_C_vaccine
is infected with. There are a total of six different HCV genotypes. Knowing the specific genotype of the virus is important when deciding on treatment
Hepatitis C and HIV coinfection
Hepatitis_C_and_HIV_coinfection
Visual disorder
Retrieved August 1, 2024. Perić, Magdalena (2014-05-15). "Most common HCV genotypes in patients from north-eastern Croatia". Acta Medica Academica. 43 (1):
Prosopometamorphopsia
Chemical compound
co-formulation with an HCV NS5A inhibitor pibrentasvir. Together they demonstrated potent antiviral activity against major HCV genotypes and high barriers
Glecaprevir
Protein-coding gene in the species Homo sapiens
conducted on HCV genotype 1, but the association between IFNL4 genotype and impaired HCV clearance has been observed for other HCV genotypes as well. IFNL4-ΔG/TT
Interferon_lambda_4
Pharmaceutical compound
virus (HCV). In China, netansavir is approved for use in combination with encofosbuvir for the treatment of adult patients with chronic HCV genotypes 1, 2
Netanasvir
Chemical compound
infected with HCV genotypes 1 or 3. Data from this study in patients with HCV genotypes 2 and 6 are limited, and data on patients with genotypes 4 or 5 are
Ravidasvir
Chemical compound
combination with other drugs is part of all first-line treatments for HCV genotypes 1, 2, 3, 4, 5, and 6, and is also part of some second-line treatments
Sofosbuvir
Antiretroviral medication
ombitasvir/paritaprevir/ritonavir for the treatment of hepatitis C virus (HCV) genotype 4. After the start of the COVID pandemic in 2020, many antivirals, including
Ritonavir
Medication used to treat hepatitis C
infected with genotype 1 (46% of HCV cases). It has also been evaluated for the treatment of infection with other hepatitis C genotypes, and has shown
Ledipasvir/sofosbuvir
Chemical compound
inhibitor used to treat hepatitis caused by hepatitis C virus (HCV) genotype 1. It binds to the HCV nonstructural protein 3 active site. It was initially developed
Boceprevir
Hepatitis C drug
combination tablet for genotype 1 hepatitis C. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and
Ledipasvir
Pharmaceutical compound
virus (HCV). In China, encofosbuvir is approved for use in combination with netanasvir for the treatment of adult patients with chronic HCV genotypes 1, 2
Encofosbuvir
Two drug combination for the treatment of hepatitis C
(an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and treatment-experienced patients
Elbasvir/grazoprevir
Combination drug
hepatitis C virus (HCV) genotypes 1–6 and both without cirrhosis and with compensated cirrhosis who have not been previously treated for HCV (treatment-naïve)
Glecaprevir/pibrentasvir
Medication
clinical candidate based on its favorable potency profile against multiple HCV genotypes 1–6 and key mutants (GT1b, IC50 = 0.2–0.4 nM; replicon GT1b, EC50 =
Danoprevir
Drug for the treatment of hepatitis C
and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis". Journal of
Coblopasvir
Chemical compound
for the treatment of HCV genotype 1, and with paritaprevir and ritonavir in the product Technivie for the treatment of HCV genotype 4. Ombitasvir is an
Ombitasvir
Drug discovery
inhibitor ABT-530 are considered active against all HCV genotypes, including the hard to treat genotype 3. In vitro, ABT-530 showed potency against the resistance
Discovery and development of NS5A inhibitors
Discovery_and_development_of_NS5A_inhibitors
Signaling proteins released by host cells in response to the presence of pathogens
case of hepatitis C. The most common strain of hepatitis C virus (HCV) worldwide—genotype I— can be treated with interferon-α, ribavirin and protease inhibitors
Interferon
Viral protein
forms have been determined based on the same consensus sequence BK (HCV-BK, genotype 1). The structure can be represented by a right hand shape with fingers
Hepatitis C virus nonstructural protein 5B
Hepatitis_C_virus_nonstructural_protein_5B
NS5A inhibitor antiviral agent
C virus (HCV) NS5A protein, which plays a key role in viral RNA replication and virion assembly.. It is active against multiple HCV genotypes and has demonstrated
Pibrentasvir
Class of pharmaceutical drugs
and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase". Journal of Medicinal Chemistry. 55 (2): 754–765. doi:10
NS5B_inhibitor
1993 the first commercial test for Hepatitis C virus (HCV) genotyping worldwide (INNO-LiPA HCV). In 1995, the first commercial Alzheimer's disease research
Innogenetics
Changes in cells caused by viruses
composition of the virus. HCV genotype 3 patients are significantly more likely to develop liver steatosis than those with genotype 1. Also, CPEs may be used
Cytopathic_effect
Species of the genus Orthohepadnavirus
divided into ten genotypes (A–J) and forty subgenotypes according to overall nucleotide sequence variation of the genome. The genotypes have a distinct
Hepatitis_B_virus
Chemical compound
with both HIV and HCV. Furthermore, a recent meta-analysis of six published six clinical trials showed high response rates in HCV genotype 1-infected patients
Beclabuvir
Chemical compound
performed well in HCV genotype 1b patients. Efficacy fell below 50%, however, for dual regimens without ribavirin and for genotype 1a patients.[citation
Deleobuvir
Chemical compound
use against hepatitis C genotype 1 viral infections and has not been proven to be safe or effective when used for other genotypes of the virus. The standard
Telaprevir
Liver inflammation from a viral infection
HBV and HCV. HCV viral levels can be reduced to undetectable levels by a combination of interferon and the antiviral drug ribavirin. The genotype of the
Viral_hepatitis
Inflammation of the liver
ribavirin, based on the patient's genotype, delineated as genotypes 1–6. Genotype 1 (GT1), which is the most prevalent genotype in the United States and around
Hepatitis
Mammalian protein found in humans
first days of elimination of HCV RNA ("first phase decline") during interferon/ribavirin therapy for all HCV genotypes. This also applies for patients
CXCL10
increase the risk in a subsequent pregnancy. All genotypes appear to have the same risk of transmission. HCV infection is frequently found in children who
HCV_in_children_and_pregnancy
Combination drug
hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor; velpatasvir, an HCV NS5A inhibitor; and voxilaprevir an HCV NS3/4A protease inhibitor
Sofosbuvir/velpatasvir/voxilaprevir
Sofosbuvir/velpatasvir/voxilaprevir
Egyptian physician (born 1956)
trial to evaluate the efficacy of pegylated interferon for treatment of HCV genotype 4. In 2009, Esmat established the Kasr el Ainy viral hepatitis treatment
Gamal_Esmat
Chemical compound
therapy for HCV. Simeprevir is generally used for HCV genotype 1 infected subjects, but off-label medical use has been indicated for type 4 genotype as well
Simeprevir
Epidemiology of American prisons
and type of treatment required. Facilities use the inmates' HCV testing history, genotype, HCV treatment, HIV status and, if HIV infected, most recent CD4/T-Helper
Infectious diseases within American prisons
Infectious_diseases_within_American_prisons
Chemical compound
is a potent competitive reversible inhibitor of NS3/4A protease from HCV genotype 1a (Ki = 0.3 nM) and 1b (Ki = 0.66 nM). It shows good selectivity for
Ciluprevir
the HPV sequence. Its structure is indeed highly conserved between HCV genotypes, with a flexible helix in residues 3-11 and an alpha helix in residues
Hepatitis C virus nonstructural protein 2
Hepatitis_C_virus_nonstructural_protein_2
Antiviral medication
syncytial virus (RSV) and hepatitis C virus (HCV) infections, as well as some viral hemorrhagic fevers. For HCV, it is used in combination with other medications
Ribavirin
Genus of viruses
vertebrate. Hepatitis C virus (HCV), which is the causative agent of hepatitis C in humans, was discovered in 1989. Eight genotypes (1–8) and eighty-six subtypes
Orthohepacivirus
Israeli hepatologist and academic
C virus (HCV) response, showcasing a significant enhancement in viral response rates among treatment-naïve patients with chronic HCV genotype 1 infection
Nimer_Assy
American pharmaceutical company
treatment for hepatitis C cures the patient in 94% to 99% of cases (HCV genotype 1). By 2017, Gilead was reporting drastic drops in Sovaldi revenue from
Gilead_Sciences
Chemical compound
medication used in combination with other medications to treat hepatitis C (HCV). The other medications used in combination include sofosbuvir, ribavirin
Daclatasvir
Drug approved for the treatment of hepatitis C
the NS3/4A protease targets. It has good activity against a range of HCV genotype variants, including some that are resistant to most currently used antiviral
Grazoprevir
Defunct pharmaceutical company (1994–2002)
S2CID 33219841. Zeuzem S, Berg T, Gane E, et al. (2012). TMC435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment:
Tibotec
Protein-coding gene in the species Homo sapiens
relapse risk following interferon-based therapy for hepatitis C virus (HCV) genotype 2 or 3 infection. Holmes SL, Turner BM, Hirschhorn K (1979). "Human
ITPA
RNA family
highly conserved across different genotypes, and miR-122 is also required for replication of infectious type 2a HCV. As miRNAs generally function to repress
MiR-122
Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping". Clinical Chemistry
Restriction fragment mass polymorphism
Restriction_fragment_mass_polymorphism
Chemical compound
combination of faldaprevir, deleobuvir, and ribavirin performed well in HCV genotype 1b patients. Clinical trial number NCT01343888 for "Efficacy and Safety
Faldaprevir
Chemical compound
peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Aliment Pharmacol Ther. 2015;42(7):829-844
Alisporivir
Chemical compound
and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection". BMC Gastroenterology. 17 (1): 26. doi:10.1186/s12876-017-0580-2
TMC-647055
British virologist (born 1949)
virus (HCV) led to the rapid development of diagnostic reagents to detect HCV in blood supplies, which has reduced the risk of acquiring HCV through
Michael_Houghton
Australian physician and environmentalist
Sulkowski, Mark (31 December 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection". New England Journal of Medicine. 373 (27): 2608–2617
Lindsay_Mollison
Family of receptors found on NK cells
the genotypes of 989 individuals representing eight distinct populations found 111 distinct KIR genotypes. Individuals with the most frequent genotype, which
Killer-cell immunoglobulin-like receptor
Killer-cell_immunoglobulin-like_receptor
Pharmaceutical compound
shown to be an inhibitor against HCV in the early stages of its lifecycle. Eight of the eighteen genotypes of the HCV virus (1a, 1b, 2b, 3a, 4a, 5a, 6a
Cynaropicrin
New Zealand pharmacologist and gastroenterologist
Roberts; et al. (17 November 2015). "Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection". The New England Journal of Medicine. 373 (27): 2608–2617
Catherine_Stedman
As a heterodimer with E2 it has been discovered that it is essential for HCV entry. When the heterodimer is formed the hepatitis C virus is then able
Hepatitis C virus envelope glycoprotein E1
Hepatitis_C_virus_envelope_glycoprotein_E1
Journal of Medicine. 72 (8): 388–400. PMID 25387551. Gish RG (2006). "Treating HCV with ribavirin analogues and ribavirin-like molecules". The Journal of Antimicrobial
List_of_antiviral_drugs
Combination drug
and is currently marketed in Iran as the treatment of choice for all genotypes of hepatitis C as recommended by the national Iranian guideline for treating
Sofosbuvir/daclatasvir
Regular measurement of the viral load of HIV-positive people
the original on June 28, 2009. Retrieved 2012-10-16. "TRUGENE® HIV-1 Genotyping Kit and OpenGene® DNA Sequencing System- BK110007". Fda.gov. 2011-03-10
Viral_load_monitoring_for_HIV
Chemical compound
infection. It is used in the following HCV subtypes: genotype 1a, genotype 1b, genotype 1 of unknown subtype, and genotype 1 mixed infection without cirrhosis
Dasabuvir
Case in which having two different versions of a gene provides an advantage
A significantly lower proportion of HLA-DRB1 heterozygosity exists among HCV-infected cases than uninfected cases. The differences were more pronounced
Heterozygote_advantage
Chemical compound
Organization. p. 322. "Setrobuvir". AdisInsight. Retrieved 28 August 2017. "HCV Followup: Anadys Acquired for Active Antiviral". Chemical & Engineering News
Setrobuvir
Chemical compound
malignancies. Indications Treatment of chronic hepatitis C virus (HCV) infection genotype 1 in combination with ritonavir, pegylated interferon alfa and
Narlaprevir
British physician
Oxford. She has studied hepatitis C and the development of the development of HCV vaccines. She is a Fellow of the Academy of Medical Sciences and serves as
Eleanor_Barnes
Italian researcher
C virus and provided the first evidences of clinical differences of HCV genotypes. She then conducted research on the mechanisms of carcinogenesis, identifying
Patrizia_Pontisso
The infectious disease hepatitis C is caused by the hepatitis C virus (HCV), which affects the liver. During the initial infection, people often have
List of people with hepatitis C
List_of_people_with_hepatitis_C
Pharmaceutical drug
patients with HCV. TURQUOISE II reported a 95% cure rate for the 24-week arm and 99% cure rate for the 12-week arm. Subjects with genotype 1a had higher
Ombitasvir/paritaprevir/ritonavir
Ombitasvir/paritaprevir/ritonavir
Indian microbiologist
hepatitis C. Later, at IISc, he focused on the translation of Hepatitis C Virus (HCV) and has done in vivo and in vitro experiments on the characterization of
Saumitra_Das
Experimental medication
Japanese Hepatitis C Virus (HCV) Patients". ClinicalTrials.gov. 23 September 2015. C. Reviriego (2012). "Asunaprevir. HCV serine protein NS3 inhibitor
Asunaprevir
Chemical compound
non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection". IDrugs. 13 (12): 938–48. PMID 21154154. Loftus P (8 March 2013)
Filibuvir
Cyclic sequence of self-reproducing single cycles
Piotr; Figlerowicz, Marek; Błażewicz, Jacek (2010). "Towards Prediction of HCV Therapy Efficiency". Computational and Mathematical Methods in Medicine.
Hypercycle_(chemistry)
American immunologist
virus” which discusses which genes contribute to a person’s ability to clear HCV. In 2015 she published “The impact of host genetic variation on infection
Mary_Carrington
Pharmaceutical drug
JH (May 2015). "Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma". Scientific Reports. 5 (1): 9954. Bibcode:2015NatSR
Peginterferon_alfa-2b
Research tool in genomics
aimed to dissect the host factors associated with dengue and hepatitis C (HCV) infection (two viruses in family Flaviviridae). ELAVL1, an RNA-binding protein
Genome-wide CRISPR-Cas9 knockout screens
Genome-wide_CRISPR-Cas9_knockout_screens
Medical diagnostic method
Halfon P (2008). "Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The Fibrovic study - ANRS HC02". J. Hepatol. 48 (5):
FibroTest
Medical professional who works in the laboratory
coagulation profile, lipid profile, blood type, genotype, pack cells volume (PCV), hepatitis (HbsAg and HCV), glucose test (fasting blood sugar {FBS} and
Medical_laboratory_scientist
carcinoma (primary liver cancer). There have been many hepatitis C virus (HCV) epidemics in history. Pandemic portal Globalization and disease History
List of epidemics and pandemics
List_of_epidemics_and_pandemics
Protein-coding gene in the species Homo sapiens
for chronic hepatitis C, as well as spontaneous clearance of hepatitis C (HCV) infection. The gene then known as IL28B (now IFNL3) was the closest known
Interferon_lambda_3
tumors Glecaprevir/pibrentasvir The treatment of acute hepatitis C virus (HCV) infection in adults and pediatric patients ages 3 to less than 18 years
List of drugs granted breakthrough therapy designation
List_of_drugs_granted_breakthrough_therapy_designation
Mammalian protein found in Homo sapiens
1996). "Characterization of functional domains in the human coronavirus HCV 229E receptor". The Journal of General Virology. 77 (10): 2515–2521. doi:10
Alanine_aminopeptidase
Chemical compound
Hu B, et al. (December 2013). "Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity". ChemMedChem. 8 (12): 1930–40. doi:10.1002/cmdc
Elbasvir
Chemical compound
(March 2018). "NS5B polymerase inhibitors in phase II clinical trials for HCV infection". Expert Opinion on Investigational Drugs. 27 (3): 243–250. doi:10
Uprifosbuvir
Population structure of viruses with a large number of variant genomes
colonizers and competitors, that modulated virulence of the mutant ensemble. In HCV such a design unveiled continuous mutation waves and a more accurate understanding
Viral_quasispecies
Hermouet, Sylvie (2021). "Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma". Frontiers in Immunology
Chronic diseases and cancers linked to infectious microbes
Chronic_diseases_and_cancers_linked_to_infectious_microbes
Medication used to treat a viral infection
viral types: caliciviruses flaviviruses (including West Nile virus) dengue HCV coronaviruses Yet another antiviral technique inspired by genomics is a set
Antiviral_drug
American medical researcher
Tawhida Y; Sira, Mostafa M; El Naghi, Suzan (December 8, 2015). "Hepatitis C genotype 4: The past, present, and future". World Journal of Hepatology. 7 (28):
Harvey_J._Alter
Infectious agent that replicates in cells
PMID 17567457. S2CID 25399220. Hu J, Ludgate L (2007). "HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development". Aids-Associated Viral Oncogenesis
Virus
Protein-coding gene in the species Homo sapiens
Garo E, et al. (September 2015). "IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon
Interleukin_26
Medical condition with rash and bleeding risk
excluded including medications (quinine or heparin), viral infection (HIV or HCV), malignancy (leukemia), autoimmune conditions (systemic lupus erythematosus
Immune thrombocytopenic purpura
Immune_thrombocytopenic_purpura
have been used to sequence the whole genome of Epstein–Barr virus (EBV) and HCV, however, contaminating host nucleic acids can affect the sensitivity to
Viral_metagenomics
Relationship between cancer and the consumption of alcohol
these cases by some investigators. "Overall, 61% of HCC were attributable to HCV [hepatitis C virus], 13% to HBV [hepatitis B virus], and 18% to heavy alcohol
Alcohol_and_cancer
Technologies to genetically improve human bodies
researchers have targeted viral infections like HSV-1, EBV, HIV-1, HBV, HPV, and HCV, with ongoing clinical trials for an HIV-clearing strategy named EBT-101
Human_genetic_enhancement
Epidemiology method
Cunningham EB, Applegate TL, Lloyd AR, Dore GJ, Grebely J (2015). "Mixed HCV infection and reinfection in people who inject drugs--impact on therapy"
Source_attribution
New Zealand biologist (1938–2024)
spontaneous resolve HCV infection than to become chronic carriers". However the researchers suggested that "the prevalence and preponderance of HCV [made] it a
David_Penny
HCV GENOTYPES
HCV GENOTYPES
Boy/Male
Tamil
To possess, To hav power to rule, To govern, To be master
Boy/Male
Hindu
To possess, To hav power to rule, To govern, To be master
HCV GENOTYPES
HCV GENOTYPES
Surname or Lastname
English
English : patronymic from Crook 1.
Girl/Female
Tamil
Kshetra | கà¯à®·à¯‡à®¤à¯à®°Â
Place
Girl/Female
Hindu, Indian, Tamil
Cute Girl
Surname or Lastname
English
English : probably a variant spelling of Purcell, or alternatively of Percil (from Old French percer ‘to pierce’ + soel, suel ‘threshold’).
Boy/Male
Hawaiian
Gift of God; gift from God.
Girl/Female
Muslim
Pure, Clean, Neat, Chaste
Boy/Male
German English
Intelligent or noble.
Biblical
help of God, court of God
Boy/Male
Hindu
Correct message
Surname or Lastname
English (mainly Lincolnshire)
English (mainly Lincolnshire) : patronymic from the medieval personal name Hudde (see Hutt 1).
HCV GENOTYPES
HCV GENOTYPES
HCV GENOTYPES
HCV GENOTYPES
HCV GENOTYPES